Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

ClinicalTrials.gov ID: NCT00140036

Public ClinicalTrials.gov record NCT00140036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00140036
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
137 participants

Conditions and interventions

Interventions

  • Blood draw Procedure

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2002
Primary completion
Not listed
Completion
Jul 31, 2005
Last update posted
Mar 2, 2008

2002 – 2005

United States locations

U.S. sites
29
U.S. states
23
U.S. cities
29
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Tucson Arizona 85715
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site Stamford Connecticut 06902
Pfizer Investigational Site Washington D.C. District of Columbia 20007
Pfizer Investigational Site Jacksonville Florida 32207
Pfizer Investigational Site New Port Richey Florida 34652
Pfizer Investigational Site Tamarac Florida 33321
Pfizer Investigational Site Rockford Illinois 61108-2472
Pfizer Investigational Site Terre Haute Indiana 47802
Pfizer Investigational Site New Orleans Louisiana 70115
Pfizer Investigational Site Annapolis Maryland 21401
Pfizer Investigational Site Pittsfield Massachusetts 01201
Pfizer Investigational Site Minneapolis Minnesota 55422
Pfizer Investigational Site Columbia Missouri 65212
Pfizer Investigational Site Billings Montana 59101
Pfizer Investigational Site Las Vegas Nevada 89106
Pfizer Investigational Site Hooksett New Hampshire 03106
Pfizer Investigational Site Lebanon New Hampshire 03756
Pfizer Investigational Site Rockville Centre New York 11570
Pfizer Investigational Site Greenville North Carolina 27834
Pfizer Investigational Site Hendersonville North Carolina 28738
Pfizer Investigational Site Hickory North Carolina 28602
Pfizer Investigational Site Winston-Salem North Carolina 27157
Pfizer Investigational Site Zanesville Ohio 43701
Pfizer Investigational Site Charleston South Carolina 29406
Pfizer Investigational Site Temple Texas 76508
Pfizer Investigational Site Newport News Virginia 23606
Pfizer Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00140036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2008 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00140036 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →